GTBP
GT Biopharma Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website gtbiopharma.com
- Employees(FY) 2
- ISIN US36254L3087
Performance
-3.36%
1W
-15.68%
1M
-26.93%
3M
-55.17%
6M
-59.22%
YTD
-63.22%
1Y
Profile
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias; and GTB-5550 that is in preclinical studies for treating patients with B7-H3 positive solid tumors. GT Biopharma, Inc. has a co-development partnership agreement with Altor BioScience Corporation for the clinical development of a 161533 TriKE fusion protein for cancer therapies; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in Brisbane, California.
Technical Analysis of GTBP 2024-05-10
Overview:
In analyzing the technical indicators for GTBP over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Indicators:
- Moving Averages (MA): The 5-day MA has been fluctuating around the closing prices, ...
Recent News & Updates
- 2024-05-15 22:53
GTBP Stock Earnings: GT Biopharma Beats EPS for Q1 2024(Investorplace)
- 2024-05-15 05:00
- 2024-03-26 09:53
GTBP Stock Earnings: GT Biopharma Beats EPS for Q4 2023(Investorplace)
- 2024-03-26 05:00
- 2024-01-31 22:00
GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split(Globenewswire)
- 2023-12-05 20:30
- 2023-12-03 20:30
- 2023-11-05 20:30
- 2023-10-31 21:00
GT Biopharma Reports Third Quarter 2023 Financial Results(Globenewswire)
- 2023-08-06 21:00
GT Biopharma Reports Second Quarter 2023 Financial Results(Yahoo Finance)
- 2023-08-03 01:25
- 2023-05-15 05:00
- 2023-05-03 21:05
- 2023-04-11 19:07
Daily Vickers Top Buyers & Sellers for 04/12/2023(Yahoo Finance)
- 2023-03-30 05:00
- 2023-02-23 20:00
- 2023-02-01 20:46
- 2022-12-29 19:00
- 2022-12-13 18:30
- 2022-12-11 18:30
- 2022-11-10 02:15
- 2022-11-02 21:00
- 2022-10-31 05:15
- 2022-10-25 02:44
- 2022-10-05 20:18
- 2022-10-04 04:10
- 2022-09-11 21:34
- 2022-09-07 19:30
- 2022-08-30 06:00
- 2022-08-10 21:35
Page 1 of 4
previousnext